IL4 and neoplasm: In line with the results of Th1 differentiation (Fig. 9a), combined treatment of anti-IL-4 and anti-IL-21 Abs significantly reversed the impaired induction and function of tumour-specific CD8+ T cells in response to tumour inoculation in aged mice.